-
January 11: The Week in Cancer News
Government guidance asks hospitals to post prices online, and a study shows that cancer patients are less likely to enroll in clinical trials if they have coexisting health conditions.
by Kate Yandell
-
January 4: The Week in Cancer News
A financial transparency law goes into effect, researchers investigate a link between hot flashes and breast cancer, and the hunt for a better synthetic cell culture medium.
by Brad Jones
-
December 21: The Week in Cancer News
Judicial threats to the Affordable Care Act continue, and a study investigates the long-term risks of chemotherapy.
by Kate Yandell and Marci A. Landsmann
-
December 14: The Week in Cancer News
A long-term trial presents new evidence on who should have surgery for localized prostate cancer, and a review finds that women are temporarily at increased risk of breast cancer after giving birth.
by Kate Yandell
-
December 7: The Week in Cancer News
A trial tests a new treatment for some patients with early-stage breast cancer, and studies assess how long the benefits of CAR-T cell therapy last for patients with non-Hodgkin lymphoma.
by Kate Yandell
-
November 30: The Week in Cancer News
A study warns that popular YouTube videos about prostate cancer may be misleading, and the U.S. Food and Drug Administration approves a therapy based on tumor genetics, not tumor origin.
by Kate Yandell
-
November 16: The Week in Cancer News
A study links adolescent obesity to adult pancreatic cancer risk, and “Batkid” turns 10 years old.
by Bradley Jones
-
November 9: The Week in Cancer News
A study assesses how timing affects the outcomes of pregnancy after cancer treatment, and researchers present on the benefits of Medicaid expansion for breast cancer patients.
by Kate Yandell
-
November 2: The Week in Cancer News
A survey shows that 39 percent of Americans believe that alternative therapies can cure cancer, and a trial finds that minimally invasive surgery is inferior to traditional surgery for treating cervical cancer.
by Kate Yandell
-
October 26: The Week in Cancer News
Researchers present cancer clinical trial results at the ESMO 2018 Congress, and a study shows that crowdfunding campaigns are raising money for unproven cancer treatments.
by Kate Yandell
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles